Search Results

There are 25558 results for: content related to: Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer

  1. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer

    The Journal of Pathology

    Volume 231, Issue 4, December 2013, Pages: 505–516, Roopika Menon, Mario Deng, Kerstin Rüenauver, Angela Queisser, Martin Pfeifer, Anne Offermann, Diana Boehm, Wenzel Vogel, Veit Scheble, Falko Fend, Glen Kristiansen, Nicolas Wernert, Nicole Oberbeckmann, Saskia Biskup, Mark A Rubin, Zaki Shaikhibrahim and Sven Perner

    Version of Record online : 12 NOV 2013, DOI: 10.1002/path.4274

  2. Variant allele of HSD3B1 increases progression to castration-resistant prostate cancer

    The Prostate

    Volume 75, Issue 7, May 15, 2015, Pages: 777–782, Gang Wu, Shengsong Huang, Kent L. Nastiuk, Jinliang Li, Jun Gu, Ming Wu, Qimin Zhang, Hanqing Lin and Denglong Wu

    Version of Record online : 1 MAR 2015, DOI: 10.1002/pros.22967

  3. You have free access to this content
    New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  4. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Version of Record online : 24 APR 2012, DOI: 10.3322/caac.21141

  5. The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1247–1254, Zhibin Chen, Ni Chen, Pengfei Shen, Jing Gong, Xiang Li, Tao Zhao, Banghua Liao, Liangren Liu, Zhenhua Liu, Xingming Zhang, Jiyan Liu, Zhufeng Peng, Xueqin Chen, Miao Xu, Haojun Gui, Peng Zhang, Qiang Wei, Qiao Zhou and Hao Zeng

    Version of Record online : 27 APR 2015, DOI: 10.1002/pros.23005

  6. Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer

    The Prostate

    Volume 73, Issue 6, May 2013, Pages: 657–667, Anna Nordin, Wanzhong Wang, Karin Welén and Jan-Erik Damber

    Version of Record online : 5 NOV 2012, DOI: 10.1002/pros.22607

  7. Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer

    The Prostate

    Volume 72, Issue 14, 1 October 2012, Pages: 1491–1505, John T. Isaacs, Jason M. D'Antonio, Shuangling Chen, Lizamma Antony, Susan P. Dalrymple, Georges H. Ndikuyeze, Jun Luo and Samuel R. Denmeade

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pros.22504

  8. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

    The Prostate

    Volume 72, Issue 10, 1 July 2012, Pages: 1093–1103, Tong Sun, Ming Yang, Shaoyong Chen, Steven Balk, Mark Pomerantz, Chen-Lin Hsieh, Myles Brown, Gwo-Shu Mary Lee and Philip W. Kantoff

    Version of Record online : 29 NOV 2011, DOI: 10.1002/pros.22456

  9. You have free access to this content
    Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 109, Issue 7, April 2012, Pages: 968–985, Daniel J. Lee, Eugene K. Cha, Justin M. Dubin, Himisha Beltran, Thomas F. Chromecki, Harun Fajkovic, Douglas S. Scherr, Scott T. Tagawa and Shahrokh F. Shariat

    Version of Record online : 28 OCT 2011, DOI: 10.1111/j.1464-410X.2011.10643.x

  10. Anterior gradient 2 (AGR2): Blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype

    The Prostate

    Volume 73, Issue 3, 15 February 2013, Pages: 306–315, Kian Kani, Paymaneh D. Malihi, Yuqiu Jiang, Haiying Wang, Yixin Wang, Daniel L. Ruderman, David B. Agus, Parag Mallick and Mitchell E. Gross

    Version of Record online : 21 AUG 2012, DOI: 10.1002/pros.22569

  11. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer

    The Prostate

    Volume 72, Issue 11, 1 August 2012, Pages: 1171–1178, Bin Xu, Ning Wang, Xuhui Wang, Na Tong, Ning Shao, Jun Tao, Pengchao Li, Xiaobing Niu, Ninghan Feng, Lihua Zhang, Lixin Hua, Zengjun Wang and Ming Chen

    Version of Record online : 7 DEC 2011, DOI: 10.1002/pros.22466

  12. You have free access to this content
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Version of Record online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  13. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells

    The Prostate

    Volume 75, Issue 7, May 15, 2015, Pages: 693–705, Kiren Yacqub-Usman, Mark R. Pickard and Gwyn T. Williams

    Version of Record online : 3 FEB 2015, DOI: 10.1002/pros.22952

  14. You have free access to this content
    Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 14–22, Noel W. Clarke

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11430.x

  15. You have full text access to this OnlineOpen article
    The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer

    Cancer Medicine

    Volume 3, Issue 2, April 2014, Pages: 245–251, Weranja K. B. Ranasinghe, Shomik Sengupta, Scott Williams, Mike Chang, Arthur Shulkes, Damien M. Bolton, Graham Baldwin and Oneel Patel

    Version of Record online : 27 JAN 2014, DOI: 10.1002/cam4.189

  16. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer

    The Prostate

    Volume 75, Issue 6, May 1, 2015, Pages: 616–627, Yixuan Gong, Uma D. Chippada-Venkata, Matthew D. Galsky, Jiaoti Huang and William K. Oh

    Version of Record online : 5 JAN 2015, DOI: 10.1002/pros.22945

  17. The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines

    PROTEOMICS

    Volume 12, Issue 13, July 2012, Pages: 2115–2126, Kathleen O'Connell, Maria Prencipe, Amanda O'Neill, Claire Corcoran, Sweta Rani, Michael Henry, Paul Dowling, Paula Meleady, Lorraine O'Driscoll, William Watson and Robert O'Connor

    Version of Record online : 17 JUL 2012, DOI: 10.1002/pmic.201100489

  18. Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer

    Histopathology

    Volume 60, Issue 4, March 2012, Pages: 645–652, Tarek A Bismar, Maisa Yoshimoto, Qiuli Duan, Shuhong Liu, Kanishka Sircar and Jeremy A Squire

    Version of Record online : 19 JAN 2012, DOI: 10.1111/j.1365-2559.2011.04116.x

  19. Recent Developments in Androgen Receptor Antagonists

    Archiv der Pharmazie

    Volume 348, Issue 11, November 2015, Pages: 757–775, Fansheng Ran, Hualu Xing, Yang Liu, Daoguang Zhang, Pengzhan Li and Guisen Zhao

    Version of Record online : 13 OCT 2015, DOI: 10.1002/ardp.201500187

  20. You have free access to this content
    Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 328–335, A. Oliver Sartor and John M. Fitzpatrick

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1464-410X.2011.10818.x